OBIOOrchestra BioMed Holdings, Inc.
What is the market doing?
No clear lean: rangebound and moderately shorted.
Choppy, but holding above its 200-day average. Price is +24% vs its 200-day average.
Moderately shorted, settled Sep 30, 2026, about a week of normal trading to cover.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How OBIO is trading
Orchestra BioMed Holdings, Inc. is +57% over the past year while the S&P 500 is +16%: 41 points ahead of the market.
1-year return · S&P 500 +16%
- vs 200-day average
- +24%
vs 200-day average · a clear uptrend
- RSI (14)
- 40
RSI (14) · neutral
- Below its 52-week high
- 12%
Below its 52-week high
Details›
- Last close2026-10-23
- $5.59
- 1 monthS&P 500 −0.94%
- −5.8%
- 1 yearS&P 500 +16%
- +57%
- 5 yearsS&P 500 +86%
- −43%
- vs 50-day average$5.63
- −0.88%
- 52-week high
- $6.36
- 52-week low
- $3.49
- Annualised volatility
- 81%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-22
- $158K
| Year | Return |
|---|---|
| 2026 (year to date) | +35% |
| 2025 | +3.8% |
| 2024 | −56% |
| 2023 | −8.5% |
| 2022 | −0.99% |
| 2021 | −21% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 6 | 1 of 6 | −5.0% |
| Feb | 6 | 4 of 6 | +3.1% |
| Mar | 6 | 2 of 6 | +12% |
| Apr | 6 | 1 of 6 | −12% |
| May | 6 | 2 of 6 | +6.4% |
| Jun | 6 | 3 of 6 | −5.3% |
| Jul | 6 | 1 of 6 | −3.7% |
| Aug | 6 | 2 of 6 | +1.9% |
| Sep | 7 | 4 of 7 | +4.3% |
| Oct | 7 | 3 of 7 | +0.21% |
| Nov | 6 | 5 of 6 | +14% |
| Dec | 6 | 4 of 6 | +1.5% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.